Search Orphan Drug Designations and Approvals
-
Generic Name: | Busulfan |
---|---|
Date Designated: | 04/21/1994 |
Orphan Designation: | For use as preparative therapy for malignancies treated with bone marrow transplantation. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Sparta Pharmaceuticals, Inc. 111 Rock Road Horsham, Pennsylvania 19044 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-